The case for a suitable risk assessment by Trusts dealing with biocides used in endoscope reprocessing is put by JOAN GRAY RGN, director of clinical education at Sterilox Technologies International.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
